Percutaneous treatment with Mitraclip for functional mitral regurgitation: medium-term follow up according to left ventricular function | Zendy

Isaac Pascual | Zendy; Tomas BenitoGonzález | Zendy; Daniel HernándezVaquero | Zendy; Rodrigo EstévezLoureiro | Zendy; Rebeca Lorca | Zendy; Carmen GarroteColoma | Zendy; Pablo Avanzas | Zendy; Javier Gualis | Zendy; Antonio Adeba | Zendy; Armando Pérez de Prado | Zendy; César Morı́s | Zendy; Felipe FernándezVázquez | Zendy

Open Access

Percutaneous treatment with Mitraclip for functional mitral regurgitation: medium-term follow up according to left ventricular function

Author(s) -

Isaac Pascual,

Tomas BenitoGonzález,

Daniel HernándezVaquero,

Rodrigo EstévezLoureiro,

Rebeca Lorca,

Carmen GarroteColoma,

Pablo Avanzas,

Javier Gualis,

Antonio Adeba,

Armando Pérez de Prado,

César Morı́s,

Felipe FernándezVázquez

Publication year - 2020

Publication title -

annals of translational medicine

Language(s) - English

Resource type - Journals

eISSN - 2305-5847

pISSN - 2305-5839

DOI - 10.21037/atm.2020.02.122

Subject(s) - mitraclip , ejection fraction , medicine , mitral regurgitation , functional mitral regurgitation , cardiology , percutaneous , clinical endpoint , surgery , heart failure , clinical trial

The MitraClip edge-to-edge technique is a safe and effective procedure for the treatment of FMR. In this study, patients with LVEF >30% treated with Mitraclip presented better clinical cardiovascular outcomes than those with a LVEF ≤30%. Regardless clinical outcomes, at the end of the follow-up, there was a sustained reduction in MR grades and an important improvement in NYHA functional class.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research